The rollout of a Medicare program utilizing artificial intelligence for prior authorization has been criticized as rushed and fraught with issues, as revealed by over a thousand pages of recently released documents. This pilot program, known as the Wasteful and Inappropriate Service Reduction model (WISeR), commenced in January and mandates that healthcare providers obtain approvals for specific procedures and products, including skin substitutes and epidural injections for pain management.
Operating in states such as New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington, the WISeR initiative is set to continue until 2031. However, the documents obtained by the Electronic Frontier Foundation through a Freedom of Information Act lawsuit indicate significant concerns. Notably, one vendor involved in the project cautioned the Centers for Medicare and Medicaid Services (CMS) that launching the program by the desired timeline was unrealistic.
The implications of these findings raise critical questions about the efficacy and reliability of AI in healthcare decision-making, potentially impacting patient care and provider operations across the participating states.
Use the database as your supply chain compass →
